Figure 6.MB protects HFSCs from glucagon-like peptide-1 receptor agonist (GLP-1 RA) induced cytotoxicity. (A) Representative Western blot showing GLP-1R expression across different cell types. (B) HFSCs were cultured on precoated dishes and treated with MB or vehicle for up to 7 days, followed by re-culturing with varying concentrations of GLP-1R agonists for 5 days. Cell proliferation was assessed by manual cell counting. (C) Representative bright field images of (B).
